Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Effects of Enalaprilat on Flow Distribution in Post-BCPC Patients
NCT00741156Phase 3Completed
- Sponsor
- SickKids
- Start
- Jul 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of enalaprilat in single ventricle heart defect (SV), sponsored by SickKids. Primary endpoints: Systemic Blood Flow, Pulmonary Blood Flow and 4 more. Started Jul 2008; status: completed.
02
Drugs
enalaprilat
03
Conditions
single ventricle heart defect (SV)
Beyond the preview
Go deeper on NCT00741156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00741156.